MC

Merck & Co., Inc.

13F
Merck & Co., Inc.
Last update 2025-05-15 12 Stocks (0 new)
Value $164.00 Mil Turnover 1 %
Countries:
Top Holdings: MRNA(39.83%)PSNL(30.01%)KYMR(12.86%)TRDA(9.57%)ALEC(2.65%)
Summary Stock Picks Current Portfolio
Merck & Co., Inc. Top Holdings of 2025-03-31 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
MRNA
Moderna Inc
2,308,190
65,437.2
0%
39.830
0%
0.600
+30.29%
-22.56%
12,453.1
Biotechnology
PSNL
Personalis Inc
14,044,943
49,297.8
0%
30.010
0%
15.900
+103.13%
+12.11%
572.3
Medical Diagnostics & Research
KYMR
Kymera Therapeutics Inc
772,165
21,134.2
0%
12.860
0%
1.190
+78.48%
+15.21%
3,251.8
Biotechnology
TRDA
Entrada Therapeutics Inc
1,739,768
15,727.5
0%
9.570
0%
4.580
-21.53%
-63.10%
242.1
Biotechnology
ALEC
Alector Inc
3,545,719
4,361.2
0%
2.650
0%
3.550
+81.50%
-11.64%
167.0
Biotechnology
EVAX
Evaxion Biotech AS
1,214,126
2,246.1
+1,019.47%
1.370
+1.25%
19.210
+102.44%
-37.31%
16.7
Biotechnology
STRO
Sutro Biopharma Inc
2,723,509
1,771.9
0%
1.080
0%
3.220
+46.00%
-58.38%
64.7
Biotechnology
LVTX
LAVA Therapeutics NV
1,149,345
1,459.7
0%
0.890
0%
4.370
+6.87%
+47.21%
36.8
Biotechnology
VRDN
Viridian Therapeutics Inc
93,414
1,259.2
0%
0.770
0%
0.110
+29.86%
-11.06%
1,391.1
Biotechnology
XLO
Xilio Therapeutics Inc
1,483,758
1,074.8
0%
0.650
0%
2.870
-3.54%
-24.08%
37.5
Biotechnology

Merck & Co., Inc.'s Historical Top Holdings Breakdowns

Merck & Co., Inc.'s Top Stock Picks View Full List
Ticker
EVAX
ABSI
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
EVAX
Evaxion Biotech AS
2025-03-31
Add
Add
+1.25%
â—Ź
1.75 ($2.76) 6.03
$2.65
-3.99%
Add 1019.47%
1,214,126
1,105,670
ABSI
Absci Corp
2025-03-31
Sold Out
Sold Out
-1.01%
â—Ź
2.51 ($3.67) 5.82
$2.88
-21.53%
Sold Out
0
-998,163

Merck & Co., Inc. Total Holding History ($B)

To

Merck & Co., Inc.'s Asset Allocation

To

Merck & Co., Inc. Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Merck & Co., Inc.'s Hypothetical Growth since 2025-03-31

Merck & Co., Inc.'s Yearly Returns

Year Portfolio % % Excess Gain %

Merck & Co., Inc.'s Holdings Heat Map

Size field:

Merck & Co., Inc.'s Holdings Bubble Chart

Merck & Co., Inc. News

  • 1

Discussions on Merck & Co., Inc.

No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.